GlassScriptPhysician profile
Suneesh G Nair
NPI 1962601914
$18,640.08
in general payments reported to CMS, 2019-2025
53 companies · $9,572 in 2025
The $9,572 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,311 · 2020: $1,148 · 2021: $645 · 2022: $1,598 · 2023: $1,451 · 2024: $1,916 · 2025: $9,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,011 · Food and Beverage: $5,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,010.86 |
| Food and Beverage | $5,927.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,045.15 | 2022-2025 | |
| Glaxosmithkline, LLC. | $1,849.96 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,466.02 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Electromed, INC. | $823.34 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $733.53 | 2019-2025 | Dupixent |
| Philips North America LLC | $550.57 | 2019-2025 | (Ak6) Vest Therapy, Home Pi Undivided, Alt Therapies Undivided |
| Genzyme Corporation | $508.49 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $456.91 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.33 | 2019-2025 | Ofev, Stiolto Respimat |
| Insmed, INC. | $359.32 | 2019-2025 | Arikayce |
| Amgen INC. | $323.16 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $322.09 | 2020-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $314.84 | 2020-2025 | Wakix |
| Mallinckrodt Hospital Products INC. | $294.07 | 2022-2025 | Acthar |
| Mylan Specialty L.P. | $259.94 | 2019-2024 | Yupelri |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $257.82 | 2019-2023 | |
| United Therapeutics Corporation | $252.97 | 2019-2025 | Tyvaso, Tyvaso |
| Janssen Pharmaceuticals, INC | $205.09 | 2020-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $204.70 | 2020-2025 | Aralast, Glassia |
| Pfizer INC. | $180.41 | 2019-2024 | |
| Abbvie INC. | $166.23 | 2022-2025 | |
| Inogen, INC. | $164.07 | 2020-2023 | Inogen One G3 Oxygen Concentrator |
| Genentech USA, INC. | $112.41 | 2019 | |
| Jazz Pharmaceuticals INC. | $111.94 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.77 | 2019-2024 | |
| Verona Pharma, INC. | $89.10 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $87.22 | 2024 | Purified Cortrophin Gel |
| Circassia INC. | $77.15 | 2019-2020 | |
| Shionogi INC | $72.39 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $68.81 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $68.61 | 2022-2025 | Winrevair |
| Ethicon INC. | $66.46 | 2025 | Monarch Platform |
| Novartis Pharmaceuticals Corporation | $63.76 | 2022-2023 | |
| Inspire Medical Systems, INC. | $58.30 | 2025 | Inspire |
| Lilly USA, LLC | $51.76 | 2025 | Zepbound, Mounjaro |
| Resmed Corp | $50.35 | 2023-2025 | |
| Viatris Specialty LLC | $46.98 | 2025 | Yupelri |
| Allergan, INC. | $40.47 | 2019 | |
| Sanofi US Services INC. | $39.23 | 2025 | |
| Gilead Sciences, INC. | $34.48 | 2019 | |
| Pulmonx Corporation | $34.20 | 2023-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Vifor Pharma, INC. | $31.35 | 2025 | Veltassa |
| Baxter Healthcare | $28.42 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Axsome Therapeutics, INC. | $24.93 | 2023 | Sunosi |
| 3b Medical, INC. | $24.46 | 2025 | Luna |
| Avadel Cns Pharmaceuticals, LLC | $23.21 | 2025 | Lumryz |
| Nabriva Therapeutics, Plc | $22.86 | 2020 | |
| Biogen, INC. | $21.97 | 2023 | Spinraza |
| Shire North American Group INC | $21.43 | 2019 | |
| Phadia US INC. | $14.64 | 2025 | Immunocap |
| Sunovion Pharmaceuticals INC. | $12.08 | 2019 | |
| Fisher & Paykel Healthcare INC | $11.13 | 2019 | |
| Veran Medical Technologies, INC. | $4.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suneesh Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.